Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients

Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients

BACKGROUND: Our aim was to evaluate the cost effectiveness of 3 months’ adjuvant chemotherapy versus 6 months in high-risk (T4 stage + microsatellite stable) stage II colon cancer (CC) patients. METHODS: Using the validated PATTERN Markov cohort model, which simulates the disease progression of stag...

Full description

Saved in:
Bibliographic Details
Main Authors: Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Format: Text
Language:English
Published: SAGE Publications 2020
Subjects:
Original Research
Online Access:https://pmc.ncbi.nlm.nih.gov/articles/PMC7502861/
https://pubmed.ncbi.nlm.nih.gov/32994804
http://dx.doi.org/10.1177/1756284820954114
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://pmc.ncbi.nlm.nih.gov/articles/PMC7502861/
https://pubmed.ncbi.nlm.nih.gov/32994804
http://dx.doi.org/10.1177/1756284820954114

Similar Items